We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GE Aerospace | NYSE:GE | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
1.85 | 1.14% | 164.49 | 165.74 | 162.0101 | 165.30 | 3,967,223 | 01:00:00 |
GE Healthcare President & CEO Kieran Murphy today issued the following statement around efforts to address the coronavirus (COVID-19):
“GE Healthcare is proud to support customers, governments and the broader healthcare community in the fight against the coronavirus. Our dedicated teams are working around the clock to ensure that our customers and partners on the front lines have the equipment and servicing needed to diagnose and treat patients with COVID-19.
“To help address this global challenge, we have increased our manufacturing capacity and output of equipment – including CTs, ultrasound devices, mobile X-ray systems, patient monitors and ventilators – important in the diagnosis and treatment of COVID-19 patients, while taking steps to ensure safe operations for our employees.
“As the global pandemic evolves, there is unprecedented demand for medical equipment, including ventilators. We continue to explore all options to support this increased need. Direct actions we are taking include:
“As we continue to support our customers and partners, the health and safety of our employees remains our top priority. I am deeply proud of the work the GE Healthcare team is doing to tackle this global challenge.”
View source version on businesswire.com: https://www.businesswire.com/news/home/20200319005321/en/
For media inquiries: Amy Sarosiek Executive Director, External Communications GE Healthcare +1 224 239 6028 amy.sarosiek@ge.com
1 Year GE Aerospace Chart |
1 Month GE Aerospace Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions